Anti-Human H2BFM Therapeutic Antibody
Recombinant Humanized monoclonal antibody expressed in CHO binding to Human H2BFM. The antibodiess bind to a human histone protein, such as H2B, H3 or H4 are of use to treat a variety of diseases that may be associated with histones, such as autoimmune disease, atherosclerosis, arthritis, rheumatoid arthritis, edema, sepsis, septic shock, hyperinflammatory disorder, infectious disease, inflammatory disease, immune dysregulatory disorder, GVHD, transplant rejection, atherosclerosis, asthma, a coagulopathy, myocardial ischemia, thrombosis, nephritis, inflammatory liver injury, acute pancreatitis, ischemia-reperfusion injury, stroke, cardiovascular disease, and burn.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-335CL |
| Pricing | Inquiry |
| Type | Antibody |
| Storage | ≤1 year at -20°C. |
| Target | H2BFM |
| Species Reactivity | Human |